Emisphere Technologies Inc (OTCBB - OTCQB:EMIS)

Data as of Aug 29
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Emisphere Technologies, Inc. is a biopharmaceutical company that focuses on the commercialization of its own product candidates using its Eligen Technology, which can be applied to the oral route of administration as well other delivery pathways, such as buccal, rectal, inhalation, intra-vaginal or transdermal. Its product pipeline includes prescription drugs and medical food product candidates in varying stages of development. The company was founded in 1986 and is headquartered in Roseland, NJ.

Contact Information

Emisphere Technologies, Inc.
4 Becker Farm Road
Roseland New Jersey 07068
P:(973) 532-8000
Investor Relations:
(973) 532-8005



Individual stakeholders30.06%
Mutual fund holders--
Other institutional--

Top Executives

Alan L. RubinoPresident, Chief Executive Officer & Director
Michael R. GaroneCFO, Secretary, VP & Head-Investor Relations
M. Gary I. RileyChief Scientific Officer
Kathleen McDedeDirector-Human Resources & Information Technology
Michael PerelmanChief Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.